NEW MJ NEWS

MariMed to Host First Quarter 2021 Investor Conference Call

 

MariMed, Inc. (OTCQX: MRMD) (the “Company” or “MariMed”), a leading multi-state cannabis operator focused on health and wellness, today announced a scheduled conference call to discuss the results for its first quarter ended March 31, 2021 on Tuesday, May 18th, 2021 at 9:00 a.m. Eastern Time. The Company will report its financial results for the first quarter in advance of the call.

CONFERENCE CALL DETAILS

DATE:

Tuesday, May18th, 2021

TIME:

9:00 a.m. Eastern Time

WEBCAST:

Click to Access

DIAL-IN NUMBER:

1 (888) 664-6383

CONFERENCE ID:

72887802

REPLAY:

(416) 764-8677 or (888) 390-0541

Encore Replay Code: 903675 #
Available until 12:00 midnight Eastern Time Tuesday, June 1st, 2021

About MariMed

MariMed Inc., a multi-state cannabis operator, is dedicated to improving the health and wellness of people using cannabinoids and cannabis products. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units, keeping it at the forefront of cannabis science and innovation. Proprietary formulations created by the Company’s technicians are embedded in its industry-leading products and brands, including Betty’s Eddies™, Nature’s Heritage™, Bourne Baking Co., and Kalm Fusion™. For additional information, visit marimedinc.com.

All trademarks and service marks are the property of their respective owners.

SOURCE MariMed Inc.

View original content: http://www.newswire.ca/en/releases/archive/May2021/06/c1754.html


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Emblem Corp. (EMMBF) and Canntab Therapeutics Announce Health Canada Approval for R&D

Emblem and Canntab Therapeutics Announce Health Canada Approval for R&D of Cannabinoid-Based…

$PZOOD Reverse Split Approved

Pazoo, Inc. Reverse Split Approved – New Temporary Stock Symbol: PZOOD Pazoo,…

$XXII Announces Third Quarter 2015 Financial Results

22nd Century Group Announces Third Quarter 2015 Financial Results And Conference Call…